Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2013

01-02-2013 | Article

Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients

Authors: I. Novo-Veleiro, M. Hernández-Cabrera, F. Cañas-Hernández, E. Pisos-Álamo, A. Francés-Urmeneta, M. Delgado-Yagüe, L. Alvela-Suárez, J.-L. Pérez-Arellano

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2013

Login to get access

Abstract

According to the literature, prostatitis is a rare cause of prolonged fever without an apparent origin. However, this syndrome can be easily diagnosed using specific tests, either two-glass pre- and post-prostatic massage or the Meares–Stamey four-glass test. A retrospective study over a 5-year period (between August 1st 2006 and July 31st 2011) was performed. All patients who met the criteria for microbiological prostatitis were included and assigned to one of two groups, either a study group [paucisymptomatic infectious prostatitis (PIP)] or a control group [classic infectious prostatitis (CIP)]. Epidemiological, clinical, microbiological, and treatment-related variables were collected. A comparative study between both groups was performed. Thirty-nine patients were diagnosed with prostatitis. The main risk factors were unprotected anal intercourse, human immunodeficiency virus (HIV) infection, recent travel, and recurrent urinary tract infections. The most significant differences between the PIP (19 patients) and CIP (20 patients) groups were higher frequency of elevated inflammatory markers, higher frequency of monomicrobial etiology, and longer treatment. In monomicrobial prostatitis, the most common causative agents were coagulase-negative Staphylococcus spp., Escherichia coli, and Corynebacterium glucuronolyticum. According to the findings of this study, we believe that prostatitis should be included as a possible diagnosis in a man who complains of prolonged fever without an apparent origin and having at least one of the following risk factors: unprotected anal intercourse, HIV infection, recent travel, and recurrent urinary tract infections.
Literature
1.
go back to reference Espinosa N, Cañas E, Bernabeu-Wittel M, Martín A, Viciana P, Pachón J (2010) The changing etiology of fever of intermediate duration. Enferm Infecc Microbiol Clin 28:416–420PubMedCrossRef Espinosa N, Cañas E, Bernabeu-Wittel M, Martín A, Viciana P, Pachón J (2010) The changing etiology of fever of intermediate duration. Enferm Infecc Microbiol Clin 28:416–420PubMedCrossRef
2.
go back to reference Parra Ruiz J, Peña Monje A, Tomás Jiménez C, Parejo Sánchez MI, Vinuesa García D, Muñoz Medina L et al (2008) Clinical spectrum of fever of intermediate duration in the south of Spain. Eur J Clin Microbiol Infect Dis 27:993–995PubMedCrossRef Parra Ruiz J, Peña Monje A, Tomás Jiménez C, Parejo Sánchez MI, Vinuesa García D, Muñoz Medina L et al (2008) Clinical spectrum of fever of intermediate duration in the south of Spain. Eur J Clin Microbiol Infect Dis 27:993–995PubMedCrossRef
3.
go back to reference Oteo JA (2010) Fever of intermediate duration: new times, new tools and change of spectrum. Enferm Infecc Microbiol Clin 28:407–408PubMedCrossRef Oteo JA (2010) Fever of intermediate duration: new times, new tools and change of spectrum. Enferm Infecc Microbiol Clin 28:407–408PubMedCrossRef
4.
go back to reference de Kleijn EM, Vandenbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO): I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 76:392–400CrossRef de Kleijn EM, Vandenbroucke JP, van der Meer JW (1997) Fever of unknown origin (FUO): I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 76:392–400CrossRef
6.
go back to reference Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ (1992) Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 152:51–55PubMedCrossRef Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ (1992) Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 152:51–55PubMedCrossRef
7.
go back to reference Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237PubMedCrossRef
9.
go back to reference Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5:492–518PubMed Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5:492–518PubMed
10.
go back to reference Sharp VJ, Takacs EB, Powell CR (2010) Prostatitis: diagnosis and treatment. Am Fam Physician 82:397–406PubMed Sharp VJ, Takacs EB, Powell CR (2010) Prostatitis: diagnosis and treatment. Am Fam Physician 82:397–406PubMed
11.
go back to reference Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85–S90PubMedCrossRef Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85–S90PubMedCrossRef
12.
go back to reference Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 165:842–845PubMedCrossRef Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 165:842–845PubMedCrossRef
13.
go back to reference Leport C, Rousseau F, Perronne C, Salmon D, Joerg A, Vilde JL (1989) Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol 141:334–336PubMed Leport C, Rousseau F, Perronne C, Salmon D, Joerg A, Vilde JL (1989) Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol 141:334–336PubMed
14.
go back to reference Breyer BN, Van den Eeden SK, Horberg MA, Eisenberg ML, Deng DY, Smith JF et al (2011) HIV status is an independent risk factor for reporting lower urinary tract symptoms. J Urol 185:1710–1715PubMedCrossRef Breyer BN, Van den Eeden SK, Horberg MA, Eisenberg ML, Deng DY, Smith JF et al (2011) HIV status is an independent risk factor for reporting lower urinary tract symptoms. J Urol 185:1710–1715PubMedCrossRef
15.
go back to reference Demar M, Ferroni A, Dupont B, Eliaszewicz M, Bourée P (2005) Suppurative epididymo-orchitis and chronic prostatitis caused by Burkholderia pseudomallei: a case report and review. J Travel Med 12:108–112PubMedCrossRef Demar M, Ferroni A, Dupont B, Eliaszewicz M, Bourée P (2005) Suppurative epididymo-orchitis and chronic prostatitis caused by Burkholderia pseudomallei: a case report and review. J Travel Med 12:108–112PubMedCrossRef
16.
go back to reference Corachan M, Valls ME, Gascon J, Almeda J, Vilana R (1994) Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg 50:580–584PubMed Corachan M, Valls ME, Gascon J, Almeda J, Vilana R (1994) Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg 50:580–584PubMed
17.
go back to reference Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I (2002) Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 167:1363–1366PubMedCrossRef Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I (2002) Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 167:1363–1366PubMedCrossRef
18.
go back to reference Breyer BN, Vittinghoff E, Van Den Eeden SK, Erickson BA, Shindel AW (2012) Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men. Urology 79:188–193PubMedCrossRef Breyer BN, Vittinghoff E, Van Den Eeden SK, Erickson BA, Shindel AW (2012) Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men. Urology 79:188–193PubMedCrossRef
19.
go back to reference de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM (1993) Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 41:301–307PubMedCrossRef de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM (1993) Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 41:301–307PubMedCrossRef
20.
go back to reference Millán Rodríguez F, Orsola de los Santos A, Vayreda Martija JM, Chechile Toniolo G (1995) Manejo de las prostatitis agudas: experiencia en 84 pacientes. Arch Esp Urol 48:129–136PubMed Millán Rodríguez F, Orsola de los Santos A, Vayreda Martija JM, Chechile Toniolo G (1995) Manejo de las prostatitis agudas: experiencia en 84 pacientes. Arch Esp Urol 48:129–136PubMed
21.
go back to reference Auzanneau C, Manunta A, Vincendeau S, Patard JJ, Guillé F, Lobel B (2005) Management of acute prostatitis, based on a series of 100 cases. Prog Urol 15:40–44PubMed Auzanneau C, Manunta A, Vincendeau S, Patard JJ, Guillé F, Lobel B (2005) Management of acute prostatitis, based on a series of 100 cases. Prog Urol 15:40–44PubMed
22.
go back to reference Hara N, Koike H, Ogino S, Okuizumi M, Kawaguchi M (2004) Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis. Prostate 60:282–288PubMedCrossRef Hara N, Koike H, Ogino S, Okuizumi M, Kawaguchi M (2004) Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis. Prostate 60:282–288PubMedCrossRef
23.
go back to reference Lee SJ, Lee DH, Park YY, Shim BS (2011) A comparative study of clinical symptoms and treatment outcomes of acute bacterial prostatitis according to urine culture. Korean J Urol 52:119–123PubMedCrossRef Lee SJ, Lee DH, Park YY, Shim BS (2011) A comparative study of clinical symptoms and treatment outcomes of acute bacterial prostatitis according to urine culture. Korean J Urol 52:119–123PubMedCrossRef
24.
go back to reference Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M (1991) Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19(Suppl 3):S119–S125PubMedCrossRef Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M (1991) Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19(Suppl 3):S119–S125PubMedCrossRef
25.
go back to reference Lipsky BA, Byren I, Hoey CT (2010) Treatment of bacterial prostatitis. Clin Infect Dis 50:1641–1652PubMedCrossRef Lipsky BA, Byren I, Hoey CT (2010) Treatment of bacterial prostatitis. Clin Infect Dis 50:1641–1652PubMedCrossRef
26.
go back to reference Brook I (2004) Urinary tract and genito-urinary suppurative infections due to anaerobic bacteria. Int J Urol 11:133–141PubMedCrossRef Brook I (2004) Urinary tract and genito-urinary suppurative infections due to anaerobic bacteria. Int J Urol 11:133–141PubMedCrossRef
27.
go back to reference Galán-Sanchez F, Aznar-Marin P, Marin-Casanova P, Garcia-Martos P, Rodriguez-Iglesias M (2011) Urethritis due to Corynebacterium glucuronolyticum. J Infect Chemother 17:720–721PubMedCrossRef Galán-Sanchez F, Aznar-Marin P, Marin-Casanova P, Garcia-Martos P, Rodriguez-Iglesias M (2011) Urethritis due to Corynebacterium glucuronolyticum. J Infect Chemother 17:720–721PubMedCrossRef
Metadata
Title
Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients
Authors
I. Novo-Veleiro
M. Hernández-Cabrera
F. Cañas-Hernández
E. Pisos-Álamo
A. Francés-Urmeneta
M. Delgado-Yagüe
L. Alvela-Suárez
J.-L. Pérez-Arellano
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1738-z

Other articles of this Issue 2/2013

European Journal of Clinical Microbiology & Infectious Diseases 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.